Intracisternal A-Particle (IAP) sequences are endogenous retrovirus-like mobile elements, present at 1000 copies in the mouse genome. These elements transpose in a replicative manner via an RNA intermediate and its reverse transcription, and their transposition should therefore be tightly controlled by their transcription level. The in vivo pattern of expression of these potentially mutagenic elements had previously been analysed in normal mice, and we have now investigated their expression in transgenic mice carrying dierent oncogenes (e.g. c-myc, v-Ha-ras, SV40 T-antigen) under tissue-speci®c promoters and disclosing tumors within the brain, the mammary or salivary glands, or the lymphoid organs. Northern blot analysis of IAP expression within the resulting tumors demonstrates a lack of signi®cant and/or systematic eect of v-Ha-ras and SV40 T-antigen expression, but a systematic IAP induction in the mycinduced tumors. In this case, however, analysis of double transgenic mice obtained by crossing the tumor-prone mice with previously described transgenic mice carrying IAP reporter genes did not provide any evidence for induction of the IAP transgenes, therefore strongly suggesting that c-myc expression had an eect on only a limited number of IAP sequences ± most probably depending on their position and/or methylation state. These results strengthen the importance of in vivo studies for a correct appraisal of complex biological processes, and moderate previous conclusions derived from in vitro analyses on the general activation of IAPs by oncogenes and on the role of these transposable elements in tumorigenesis.
Introduction
Intracisternal A-Particle (IAP) sequences are moderately reiterated transposable elements (approximately 1000 copies in the mouse genome) which are closely related to retroviruses and transpose via the reverse transcription of an RNA intermediate (reviewed in Ku and Lueders, 1988; Heidmann and Heidmann, 1991) . They possess two long terminal repeats (LTRs) ± that contain the signals for the initiation and regulation of transcription ± bordering gag-pol open reading frames. They are not infectious and expectedly disclose a severely truncated env gene. Fulllength elements are 7.2 kb long, but internally deleted elements ± classi®ed into dierent subgroups each represented by a few hundred copies (Lueders and Mietz, 1986; Shen-Ong and Cole, 1982) ± have been identi®ed. At least some IAP elements should still be functional as transposition events can be detected, either directly (Heidmann and Heidmann, 1991) or indirectly via the mutations their transposition provoke, especially in tumor cells in culture where these elements are heavily transcribed and act as mutagenic agents (reviewed in Ku and Lueders, 1988; Ku, 1990 ; see also Duhl et al., 1994; Michaud et al., 1994 for germline transpositions).
The in vivo pattern of expression of IAPs is complex, owing to the large number of these elements in the genome and to possible position eects. In an extensive in vivo analysis of IAP expression in transgenic mice, using LTR-driven reporter genes, we have previously identi®ed a speci®c`niche' for expression of these elements in the stem cells of the germline (Dupressoir and Heidmann, 1996) . Expression of the IAP transgenes in these cells was found to be position-and reporter gene-independent, and therefore re¯ects an intrinsic property of these elements. It is consistent with a possible role in adaptive processes, since transposition speci®cally in the germline should result in inherited mutations. Yet, Northern blot analyses of endogenous IAP expression using appropriate probes have also revealed IAP transcripts in several mouse somatic tissues with, for instance, maximum expression in the thymus (reviewed in Ku and Lueders, 1988; Dupressoir et al., 1995) . The occurrence of such transcripts is intriguing, as expression of the IAP transgenes was not detected in these tissues, and a plausible interpretation could be that they simply originate from a limited number of IAP elements, which would be embedded for instance within domains speci®cally activated in the corresponding tissues. This interpretation was recently illustrated by the demonstration that, in the liver of the ageing mice, 450% of the IAP transcripts actually originate from a single IAP element that was cloned and mapped on chromosome 3 (Dupressoir et al., 1995; Puech et al., 1997) .
The status of IAPs in tumors ± and their possible contribution to neoplastic transformation ± is still poorly de®ned. Actually, most studies have been concerned with tumor cell lines in culture, which may dier from the situation occurring in vivo. For instance, enhanced IAP expression and particle production (up to 1000-fold) is a common aberration of tumor cells, both from transplanted tumors and from established cell lines including myeloma and neuroblastoma (Ku and Fewell, 1985) , colon tumors (Augenlicht et al., 1984) , mammary tumors (Asch and Asch, 1990; Asch et al., 1993) , as well as some cell lines treated with carcinogenic agents or X-ray irradiated (HojmanMontes de Oca et al., 1984; Hsiao et al., 1986; Begemann et al., 1988 , see also Ronai et al., 1992) . Studies on carcinogen-or viral-induced mammary carcinoma (Asch et al., 1993) and on carcinogeninduced or spontaneous hepatocellular tumors (Dragani et al., 1986 (Dragani et al., , 1987 have also revealed induction of IAP expression, but only to a limited extent (i.e. 5tenfold) and in a non-systematic manner (see Discussion). Actually, in most cases induction is essentially from truncated type ID1 IAP elements (5.4 kb transcripts), and not from the full-length ± and potentially coding ± elements (7.2 kb transcripts). Accordingly, the possible contribution of IAPs to neoplastic transformation can be questioned. Yet, transposition of IAP sequences has been observed in vitro in several tumor cell lines, possibly conferring to the cells some selective advantage for growth, as a result of their insertion close to proto-oncogenes or to genes encoding growth-factors, cytokines, or their receptors (reviewed in Ku and Lueders, 1988; Ku, 1990) . A ®nal hint for a possible role of IAPs in tumorigenesis relies on in vitro experiments using expression vectors for oncogenes, co-transfected with IAP-derived reporter genes, which have shown that the T-antigen of the simian virus 40 (SV40), and the c-myc and ras oncogene products stimulate the promoter activity of the IAP LTR at least tenfold (Luria and Horowitz, 1986; Galien et al., 1991 Galien et al., , 1994 , but see Mowat et al., 1990) .
To further investigate the status ± and possible role ± of IAPs in tumorigenesis, we have analysed IAP expression under in vivo conditions, in primary tumors of transgenic mice which develop tumors in various organs, as a result of the speci®c activation of oncogene-carrying transgenes (reviewed in Compere et al., 1988; Hanahan, 1988; Adams and Cory, 1991) . Tumors from mice with either the c-myc, vHa-ras, or SV40 T-antigen oncogenes under the control of tissue-speci®c promoters (MMTV LTR, IAP LTR, Immunoglobulin enhancer and promoter) were therefore analysed by Northern blot for the level of activation of the endogenous IAPs. In parallel, tumors from double-transgenic mice obtained by crossing these tumor-prone mice with previously derived transgenic mice carrying IAP LTR-driven reporter genes (Dupressoir and Heidmann, 1996) were analysed, to assay, in vivo, the eect of oncogenes on the activity of de®nite IAP elements. The major outcomes of this investigation are that (i) as a rule, there is no systematic induction of IAPs within primary tumors in vivo, at least under the conditions tested, although (ii) one oncogene (cmyc) ± but not the others ± activates transcription of IAPs in vivo; however (iii) induction in this case should only be to a limited number of elements ± possibly depending on their position and/or methylation state ± as it was not observed with the IAP transgene reporters. These results emphasize the importance of in vivo analyses for a correct appraisal of complex biological processes, that can be biased by in vitro studies.
Results

Tumor-prone transgenic mice and assay
We obtained from dierent sources, or generated ourselves, transgenic mice in which an oncogene of interest (T-antigen gene, c-myc or v-Ha-ras) is placed under the control of tissue-speci®c regulatory elements and therefore induces tumors within de®ned tissues. For each tumor-prone transgenic line, one heterozygous founder male was mated with previously derived LTR-lacZ heterozygous transgenic mice containing the lacZ reporter gene under the control of the IAP regulatory sequence (Dupressoir and Heidmann, 1996) . Accordingly, the resulting progeny ± the F1 generation ± included nontransgenic animals, oncogenecarrying transgenic mice, LTR-lacZ-carrying transgenic mice and double transgenic mice. The F1 oncogene-carrying transgenic mice were mated according to the same scheme, generating the subsequent generations (up to F4). All mice were assayed for their genotype by Southern blot analysis of tail DNA, using oncogene-and lacZ-speci®c probes. For each oncogene studied, total RNAs were extracted from several independent tumors arising in single and double transgenic mice (see legends to the ®gures). As controls, we used normal tissues from non-oncogenic and oncogenic mice of the same generation (exceptions will be noted). Endogenous IAP expression was revealed by using a 3.8 kb probe encompassing the internal domain of the IAP sequence and therefore revealing all classes of IAP elements. The level of oncogene-associated transcripts and the quantity of RNAs blotted on the gels were assayed by rehybridizing each blot with an oncogene-derived and a b-actin probe, respectively. When assayed, IAP-LTR transgene expression was measured by RT ± PCR as described in Dupressoir and Heidmann (1996) .
Analysis of endogenous IAP expression in tumors of oncogene-overexpressing transgenic mice SV40 T-antigen We generated transgenic mice carrying the SV40 T-antigen gene, placed under the control of the IAP LTR (named LTR-Tag mice, see Materials and methods). Two independent transgenic lines were obtained: the Tag1 line in which poorly dierentiated brain tumors developed within 3 to 6 months, including glioblastoma, astrocytoma and ependymoma as determined by histological analysis of the tumors (data not shown); the Tag170 line in which mice died when 2 month old with enlarged thymus and/or undierentiated brain tumors, and which could not be maintained beyond the F1 generation. Tumors from both transgenic lines were compared with normal brains from LTR-lacZ transgenic mice. Using an IAP probe, the two canonical 7.2 and 5.4 kb IAP transcripts (corresponding to the full-length type I and internally deleted type ID1 elements, respectively) can be detected in the normal brain (Figure 1 ). In the tumors, variations in the intensity of these two transcripts can be observed (Figure 1 ), with both decreases (e.g. lanes 2 and 3) and increases (lanes 4 and 5). Quantitation of the transcripts discloses maximal variation for the 7.2 kb transcript (from 0.3 to tenfold), with more limited eect for the 5.4 kb one (from 0.5 to twofold). Hybridization of the blots with a SV40 T-antigen probe shows, as expected, no expression of this oncogene in the control brain and signi®cant amounts of small and large T-antigen transcripts in the various tumors, but still with dierent intensities (Figure 1) . From the quantitative analysis of the data, no correlation ± either positive or negative ± can be observed between the abundance of the T-antigen transcripts and that of the IAP transcripts.
v-Ha-ras oncogene To analyse the eect of ras activation on IAP transcription, we used transgenic mice with the v-Ha-ras oncogene driven by the MMTV LTR (Sinn et al., 1987) . These mice ± both male and female ± develop mammary and salivary gland tumors within a few months. Several salivary gland and mammary tumors were analysed and compared to the nontumorigenic corresponding tissues ( Figure 2 ). As illustrated in the ®gure, only the 5.4 kb IAP transcript can be detected in the control mammary and salivary glands. The intensity of this transcript does not vary in a systematic manner among the various samples, disclosing both decreases and increases depending on the tumor (from 0.2 to twofold variation, after quantitation and correction for the amount of RNAs loaded on the gels). The 7.2 kb IAP transcript, corresponding to the full-length IAPs, could not be detected in any of the tumors. Hybridization with a ras probe disclosed, as expected, signi®cant levels of rastranscripts (although with variable intensity) in the tumors ± and not in the normal tissues. No correlation between the levels of ras and IAP transcripts can therefore be observed in vivo.
c-myc oncogene To analyse the eect of c-myc activation on IAP expression, two c-myc-overexpressing transgenic mice were assayed: (i)`myc12' transgenic mice carrying the human c-myc under its own regulatory sequences, in which the transgene is Roland and Morello, 1993) , and (ii) MMTV-myc' mice (Stewart et al., 1984) where the murine c-myc is fused to the MMTV LTR and induces mammary tumors. Thymomas of myc12 origin and mammary tumors of MMTV-myc origin were analysed together with normal corresponding tissues from control mice (see Figure 3a for three independent thymomas and two independent mammary tumors). Analysis of IAP expression demonstrates essentially the 5.4 kb transcript in the two control tissues, with high expression in the thymus as previously reported (Ku and Fewell, 1985) . In the tumors, the most salient feature is the induction of the 7.2 kb transcript which can be detected in all ± but one ± thymomas and in all mammary tumors (as well as in some cases a 6 kb transcript, in the mammary tumors). Induction is to a variable extent (e.g. lane 4 versus lanes 2 and 3) but might be as high as 10 ± 30-fold (depending on the estimate for the control level). Conversely, the 5.4 kb transcript is not signi®cantly induced (less than twofold). As shown using a c-myc probe, all the tumoral tissues ± and not the control ± disclose high level of myc transcripts. The observed correlation between myc expression and the presence of the 7.2 kb full-length IAP transcript is further strengthened by the analysis of lymphomas from two dierent transgenic lines (Figure 3b ): (i) from transgenic mice carrying the pim-1 oncogene under control of the Em enhancer and MoMLV LTR (van Lohuizen et al., 1989) , in which injection of MoMLV at the neonatal stage induced T-cell lymphomas and (ii) from transgenic mice carrying the murine c-myc oncogene fused to the Em enhancer/promoter elements (Verbeek et al., 1991) , which induces B-cell lymphomas. As illustrated in Figure 3b , the`Em-myc' lymphomas ± in which the myc transgene is expressed at a high-level ± demonstrate a signi®cant expression of the 7.2 kb fulllength IAP transcripts, whereas the`Em-pim-1' lymphomas ± in which the endogenous c-myc transcripts can hardly be detected ± do not express the 7.2 kb transcript.
Analysis of the IAP-LTR transgene in tumors of the oncogene-overexpressing transgenic mice
Some of the tumors tested by Northern blot for the expression of the endogenous IAPs (see above) developed in double transgenic mice (i.e. carrying both the LTR-lacZ and the oncogene transgene). In these tumors, we therefore analysed by RT ± PCR the level of activation of the LTR-lacZ transgene ( Figure  4 ), so as to compare it to that of the endogenous IAPs. RT ± PCR analyses were performed according to the procedure described in (Dupressoir and Heidmann, 1996) , using normal tissues from LTR-lacZ mice of the . Positions of the endogenous c-myc and the transgenic Em-myc transcripts are indicated for the Em-pim-1 and Em-myc transgenic mice, respectively. Exposure times for the Em-pim-1 and Em-myc blots are identical, i.e. 4 days for the IAP probe, 6 days for the c-myc probe and 6 h for the b-actin probe same litter as controls. Due to the presence of an intronic sequence in the terminal part of the transgene, RNA-speci®c ampli®cation ± resulting in a 349 bp fragment ± could be easily distinguished from amplification of contaminating DNA and/or unspliced RNA ± which resulted in a 369 bp fragment, see Figure 4 . For the SV40 T-antigen-expressing mice, analysis of the LTR-lacZ expression from both normal brain and tumors disclosed no dierence between the two tissues (e.g. Figure 4 , lanes 1 and 2, which correspond to the tissues in lanes 1 and 2 in Figure 1 ). For the rasexpressing mice, no expression of the LTR-lacZ transgene could be detected in the mammary tumors (the salivary gland tumors were not tested), nor actually within the control tissues (e.g. Figure 4 , lanes 3 and 4, the latter corresponding to the tumor in lane 4 in Figure 2 ). Finally, for the myc-expressing mice ± which disclose enhanced expression of the endogenous IAPs (see previous section) ± analysis of the LTR-lacZ transgene expression did not demonstrate induction in the tumors. This is illustrated in Figure 4 for two mycinduced tumors from double transgenic mice of dierent origin and which disclosed high levels of endogenous IAP induction (lanes 6 and 7 in Figure 3 ): RT ± PCR analysis (lanes 5 ± 8 in Figure 4 ) shows no induction in the tumors as compared to the corresponding normal tissues (or even a slight decrease, if any, in lane 8 as compared to lane 7). In these tumors, the induction systematically observed for the endogenous IAP full-length 7.2 kb transcript is clearly not reproduced by the LTR-lacZ transgenes.
Discussion
Northern blot analyses of IAP transcripts within tumors induced in dierent tissues (brain, mammary or salivary glands) by v-Ha-ras-or T-antigen-containing transgenes have not revealed signi®cant (less than tenfold) and/or systematic (increase or decrease) variations in the level of expression of these endogenous retroviruses. On the other hand, for the c-myc induced tumors, an increase in the level of the IAP transcripts (up to 30-fold, essentially from fulllength 7.2 kb elements) could be detected in all but one thymomas, in all lymphomas overexpressing c-myc, and in all mammary tumors. IAP induction therefore does not systematically correlate with the tumoral state of a tissue, but appears to be dependent upon the oncogene used for tumor induction. This is particularly clear for mammary tumors: IAP induction was only observed with the c-myc transgene and not with v-Ha-ras (nor with the c-neu oncogene in MMTV-neu mammary tumors, not shown), although the tumors obtained in both cases were undistinguishable, at least at the histological level. This could simply imply that some oncogenes can act directly or indirectly, as transcriptional activators of the IAPs. This conclusion would be consistent with previous in vitro data but still is questioned by the lack of induction observed in vivo at the level of the LTR-IAP transgenes, using double transgenic mice obtained by crosses between the above tumor-prone mice and previously characterized LTRlacZ mice. In these mice, the LTR-IAP transgenes ± from two independent lines ± were not induced in the cmyc-expressing tumors, whereas the endogenous IAPs were induced. This paradoxical situation can be solved assuming that the c-myc-mediated induction involves only a limited number of IAP elements, possibly subjected to position eects (see following sections).
IAPs in primary tumors versus tumor cell lines
The status of the IAPs in the present oncogene-induced tumors can be compared to that reported in the very few studies concerned with primary tumors, still with distinct etiology. Actually, a slightly divergent result concerns the systematic induction of the 5.4 kb IAP transcript observed for 12/12 carcinogen-induced or spontaneous hepatocellular tumors in (Dragani et al., 1986) . In these cases, however, the level of induction was moderate (5tenfold), as also shown for some (2/4) of the carcinogen-or virus-induced mammary carcinoma that were reported in (Asch et al., 1993) . In both series of tumors, induction of the 7.2 kb transcript (corresponding to full-length IAPs) has been only casually observed, i.e. for 1/7 and 3/5 hepatocellular tumors in B6C3F and C3H mice, respectively (Dragani et al., 1986) , and for 2/4 mammary carcinoma (Asch et al., 1993) . It therefore appears from our data and those of others that IAP induction, and especially that of full-length and potentially coding elements cannot be Figure 3a , lane 7. Amounts of 5 mg (lanes 1 to 6) or 15 mg (lanes 7, 8) of RNA were reverse-transcribed and PCR-ampli®ed as indicated in Materials and methods. Aliquots of 10 ml were loaded on 2% agarose gels and fragments visualized upon u.v. ethidium bromide staining; fragments of expected size for spliced RNA (349 bp) and for contaminating genomic DNA or unspliced RNA (369 bp) are indicated considered as unequivocally linked to the tumoral state of a tissue, which does not exclude a correlation with other parameters as observed, for example, in the mycinduced tumors. The IAP status is signi®cantly dierent in tumor cell lines. Indeed, it is an old observation that in these cells (reviewed in Ku and Lueders, 1988; Ku, 1990 and see Introduction), IAPs are heavily transcribed, up to 1000-fold more than in normal mouse tissues. The large induction of the IAPs in those cells, as compared to primary tumors, is intriguing, and questions their biological relevance for the analysis of the role of IAPs in tumorigenesis. Yet, it remains plausible that in these cell lines IAP induction results from in vitro constraints, for instance associated with the establishment of the cells in culture, or the maintenance of the tumoral phenotype for transplanted tumor cells, selecting for mutations that could be mediated by IAP transpositions. In this respect, it is noteworthy that selection of IL3-or GM-CSF-independent mutants from the D35 and FDC-P1 hematopoietic cell lines lead to the emergence of cell clones with, in most cases, an IAP element transposed 5' to the IL3 or GM-CSF genes and resulting in the autocrine production of the corresponding growth factors (DuÈ hrsen et al., 1990; Heberlein et al., 1990) . Such in vitro constraints might be dierent from those encountered in vivo in a developing primary tumor. This interpretation would also account for the limited extent of IAP induction (less than tenfold) observed in some primary mammary carcinoma in mice, as compared to both transplanted or cultured cells of the same origin (up to 100-fold) (Asch et al., 1993).
IAPs and oncogene products
Two series of in vitro experiments (Luria and Horowitz, 1986; Galien et al., 1991 Galien et al., , 1994 have shown that the IAP LTR can be transactivated 10-to 15-fold by the c-myc, ras and the T-antigen gene products, using transient expression assays within cell lines in culture transfected with oncogene expression vectors and IAP reporter genes closely related to that used in the transgenic line of the present investigation (i.e. PCtype LTR; Lueders et al., 1993) . These results are contradictory to those obtained in the present investigation ± at least for the ras and T-antigen expression vectors. Although the biological relevance of in vivo data does not need to be compared to that of in vitro experiments, analysis of both sets of data is informative. A ®rst dierence might be relevant to the amount of oncogene products, most probably much higher in a transient transfection assay than within expressing cells from transgenic mice or than in spontaneous tumors. Secondly, and most importantly, IAPs in the transfection assays are plasmidic elements, not integrated into the genome. Yet, it is noteworthy that the status of the endogenous IAPs has not been analysed in the above assays, and it therefore remains plausible that the endogenous IAPs were not induced in these experiments, at variance with the plasmidic IAPs. Altogether, it could therefore be assumed that the endogenous IAPs, which are part of the genome structure and are essentially repressed in the somatic tissues are simply less accessible to the transcription factors directly or indirectly produced by the introduced oncogenes, whereas the plasmidic IAPs which lack a chromatin environment and, further, are not methylated are accessible to such factors. In this respect, it was shown that methylation inhibits the binding of several transcription factors to ± and the subsequent activation of ± the IAP LTR (Falzon and Ku, 1991; Lamb et al., 1991) . This interpretation would be compatible with both the existence of responsive regulatory sequences in the IAP LTR, and the lack of activating eect observed for some oncogene products under in vivo conditions. Other interpretations for the dierences observed between in vitro and in vivo data could also involve factors not expressed within the cell lines assayed in vitro, that would inhibit in vivo the eect of some of the tested oncogenes. This might be the case for ras in the mammary tumors, via inhibitory associations between AP-1 complexes (which mediate the ras-dependent activation of the IAP LTR in vitro; Galien et al., 1994) and, for instance, glucocorticoõÈ d receptors (reviewed in Miner et al., 1991) .
Position eect for IAP induction
Previous studies have strongly suggested that not all IAP elements are transcribed in a given tissue or cell line. Actually, Northern blot analyses of IAP transcripts from dierent tumor cell lines (Shen-Ong and Cole, 1984; Ku and Fewell, 1985; Ku and Lueders, 1988) as well as from transplanted (Asch et al., 1993) and primary tumors (Dragani et al., 1986; Asch et al., 1993) have shown transcripts of dierent length and varying abundance, as actually observed in the present investigation. Similarly, the sequencing of cDNA synthesized in vitro from the RNAs of normal tissues or tumors has revealed only a limited number of IAP subtypes (Mietz et al., 1992; Lueders et al., 1993) . Finally, although it cannot be directly related to expression (but see Hojman-Montes de Oca et al., 1984; Feenstra et al., 1986; Hsiao et al., 1986 for the relationship between IAP hypomethylation and expression), Lueders et al. have shown that in primary plasmacytoma only a few IAP loci are demethylated (Lueders et al., 1993; Lueders and Ku, 1995) . This series of results strongly suggests that only a limited subset of IAP elements are active within a given tissue or cell line, a conclusion which is consistent with the absence of expression, in most somatic tissues, of IAPLTRs introduced in the mouse genome as transgenes (Dupressoir and Heidmann, 1996) , and with the demonstration that, in the liver of old mice, 450% of the IAP transcripts actually originate from a single IAP locus (Dupressoir et al., 1995; Puech et al., 1997) . Accordingly, the observed dierential eect of c-myc expression on the endogenous IAPs (the 7.2 kb IAP transcripts are induced) and the IAP-LTR transgenes (they are not induced) could be simply accounted for by assuming that only a very limited number of endogenous IAP elements are induced by c-myc, most probably as a result of their position close to a c-myc induced gene or domain, and/or as a result of their speci®c demethylation. This would also be consistent with the presently observed lack of induction of the 5.4 kb IAP transcript, which could be a statistical consequence of the lower copy number of the internally deleted versus full-length IAP elements (Lueders and Mietz, 1986 ; Shen-Ong and Cole, 1982).
Interestingly, if some of the full-length myc-induced IAP elements are non-defective, their signi®cant induction in the myc tumors might not be`neutral'. It could indeed be associated with IAP transpositions and mutagenesis in these cells, and therefore be involved in the progression of the tumor phenotype.
In conclusion, IAP induction does not appear to be a necessary component of the tumoral state, although it appears to be a consequence of oncogene activation in the case of c-myc. These outcomes signi®cantly dier from those derived from in vitro analyses using cell lines in culture, and therefore emphasize the importance of in vivo studies for a correct appraisal of complex biological processes. It is still possible that IAP elements participate in the induction and/or progression of some tumors, but their general involvement in these pathological processes remains elusive.
Materials and methods
Construction of LTR-Tag transgenic mice
To construct a plasmid in which the T-antigen is under the control of the LTR IAP, we replaced the lacZ+polyA sequences from the LTR-lacZ construct previously described (Dupressoir and Heidmann, 1996) , by the SV40 early region. The latter was ®rst reconstituted by subcloning in a three-fragment ligation the HincII ± PstI (nt 2666 ± 3204) and PstI ± KpnI (nt 3204 ± 294) fragments of the SV40 virus genome into an EcoRV ± KpnI opened pBluescript vector. A T-antigen gene-containing StuI ± BamHI fragment was then excised from this plasmid, blunt-ended, and subcloned into the LTR-lacZ plasmid previously opened by SalI and XhoI (to eliminate the lacZ+polyA sequences) and blunt-ended. The LTR-Tag transgene was excised as a SacII ± KpnI fragment. Generation of transgenic mice with this DNA was as previously described (Dupressoir and Heidmann, 1996) . The probe used to identify the transgenic mice is a 2.5 kb StuI ± SacI fragment (nt 5190 ± 2666 in SV40). C57BL/66DBA/2 hybrid mice were used for the production of fertilized eggs and subsequent matings.
Oncogene-expressing transgenic mice and tumors
Tumor-prone mice were as follows: MMTV-ras mice (described in Sinn et al., 1987) and MMTV-myc mice (described in Stewart et al., 1984) were purchased from Charles River, France; Em-pim-1 mice (ppG66 line, described in van Lohuizen et al., 1989) and Em-myc mice (described in Verbeek et al., 1991) were provided by A Berns; myc12A transgenic mice (described in Roland and Morello, 1993) were provided by D Morello (Pasteur Institute, France), together with RNAs of healthy thymus and thymomas. Histological analysis were carried out for each tumor for which RNA was extracted. For the MMTV-myc mice, transgenic females were mated in order to accelerate the formation of the mammary tumors. In Em-pim-1 mice, lymphoma were induced by injecting newborn mice with 10 6 p.f.u. of Moloney murine leukemia retrovirus (MoMLV). For the double transgenic mice experiments, the IAP LTR-lacZ transgenic mice used were the IL22 and IL10 lines described in (Dupressoir and Heidmann, 1996) .
RNA analyses
RNAs were isolated from organs and tumors as previously described (Dupressoir et al., 1995) . For Northern analysis, 10 mg of RNA from each organ or tumor were fractionated by electrophoresis on 1% (w/v) formaldehyde-agarose gels in 16MOPS buer, BET-stained, and transferred to Hybond N nylon ®lters (Amersham) in 0.15 M NH 4 Ac buer. Membranes were prehybridized for 30 min, hybridized for 14 h at 658C in Church solution (7% SDS, 1 mM EDTA [pH 8], 0.5 M NaPO 4 [pH 7]) without bovine serum albumin, and washed twice for 15 min at 658C in 0.56SSC, 0.1% SDS. The probes were 32 P-labeled using a random-priming kit (Amersham). Membranes were exposed to X-ray ®lms (Kodak AR) for the indicated times (see legends to ®gures), or analysed with a Phosphoimager. When needed, membranes were deshybridized for 10 min in 10 mM Tris-HCl, 1 mM EDTA, 0.1% SDS at boiling temperature, checked for complete deshybridization and then re-hybridized according to the same procedures. Amount of RNA loaded on each lane was assessed by hybridization with a b-actin probe. The probes used are: a 3.8 kb EcoRI ± HindIII fragment (nt 472 to 4295 in Ymer et al., 1986) encompassing the internal part of the IAP sequence, a 2.5 kb StuI ± SacI fragment containing the T-antigen gene, a 1.4 kb EcoRI ± ClaI fragment containing the last exon of the human c-myc gene, a 0.9 kb HindIII fragment from the v-Ha-ras gene, and a 0.6 kp PstI ± XhoI b-actin fragment isolated from pBact5 (gift from F Dautry). For RT ± PCR analysis, total RNAs (see amounts in the legends to the ®gures) were reverse-transcribed and then PCR-ampli®ed according to the procedure described in (Dupressoir and Heidmann, 1996) , with 30 cycles of ampli®cation using the t1 and t2 primers (same reference) bracketing the SV40 early region intron.
